Outpatient treatment of heart failure

Journal of Family Practice

Volumn 51, Issue 6, 2002, Pages 519-525

  McConaghy, John R ^a   Smith, Steven R ^a  

^a TOLEDO HOSPITAL   (United States)

Author keywords

Congestive heart failure; Evidence based medicine; Mortality; Prognosis; Therapy

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTITHROMBOCYTIC AGENT; BISOPROLOL; BUMETANIDE; CALCIUM CHANNEL BLOCKING AGENT; CAPTOPRIL; CARVEDILOL; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DOBUTAMINE; FUROSEMIDE; HYDRALAZINE; ISOSORBIDE DINITRATE; METOPROLOL; MILRINONE; SPIRONOLACTONE; TORASEMIDE;

ADULT; AGED; ANAEROBIC CAPACITY; ANTICOAGULATION; CONGESTIVE HEART FAILURE; DIET RESTRICTION; EVIDENCE BASED MEDICINE; EXERCISE; FEMALE; FOLLOW UP; HEART FAILURE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTPATIENT; PROGNOSIS; REVIEW; SODIUM INTAKE;

ADRENERGIC BETA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; DRUG THERAPY, COMBINATION; HEART FAILURE, CONGESTIVE; HUMANS; PROGNOSIS; RECEPTORS, ANGIOTENSIN; RISK FACTORS; SODIUM, DIETARY;

EID: 0036270026     PISSN: 00943509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (68)

1. Prevalence and mortality rate of congestive heart failure in the United States
2. The natural history of congestive heart failure. The Framingham Study
3. Cardiac failure and sudden death in the Framingham Study
4. Ambulatory care visits to physician offices, hospital outpatient departments, and emergency departments: United States, 1997
5. Readmission after hospitalization for congestive heart failure among Medicare beneficiaries
6. Heart failure. Epidemiology, etiology, and prognosis of heart failure
7. Evaluation of suspected left ventricular systolic dysfunction
8. Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure
9. Outcome of patients with congestive heart failure treated with standard versus high doses of enalapril: A multicenter study
10. Effects of enalapril on mortality in severe congestive heart failure
11. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure
12. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement (SAVE) trial
13. Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: A randomized trial. The losartan heart failure survival study (ELITE II)
14. A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure
15. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure
16. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL randomised intervention trial in congestive heart failure (MERIT-HF)
17. The cardiac insufficiency bisoprolol study II (CIBIS-II): A randomized trial
18. Beta-blockers to reduce mortality in patients with systolic dysfunction
19. Effect of carvedilol on survival in severe chronic heart failure
20. Differential effects of betablockers in patients with heart failure: A prospective, randomized, double-blind comparison of the long-term effects of metoprolol versus carvedilol
21. The effect of spironolactone on morbidity and mortality in patients with severe heart failure
22. Effect of vasodilator therapy on mortality in chronic congestive heart failure
23. Comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure
24. Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting enzyme inhibitors
25. Digitalis for treatment of congestive heart failure in patients in sinus rhythm
26. The effect of digoxin on mortality and morbidity in patients with heart failure
27. Diuretic therapy
28. Diuretic treatment for the sodium retention of congestive heart failure
29. Effect of diuresis on the performance of the failing left ventricle in man
30. Double-blind comparison of captopril alone against furosemide plus amiloride in mild heart failure
31. Thromboembolism and antithrombotic therapy in congestive heart failure
32. Antiplatelet agents versus control or anticoagulation for heart failure in sinus rhythm
33. Anticoagulation for heart failure in sinus rhythm
34. Nonpharmacologic treatment of heart failure in the elderly
35. Guidelines for the evaluation and management of chronic heart failure. Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Evaluation and Management of Heart Failure)
36. Randomized controlled trial of long-term moderate exercise training in chronic heart failure. Effects on functional capacity, quality of life, and clinical outcome
37. Exercise training in patients with severe left ventricular dysfunction. Hemodynamic and metabolic effects
38. Effects of short-term exercise training in patients with heart failure
39. Heart failure disease management: A critical review
40. Effects of a home-based intervention among patients with congestive heart failure discharged from acute hospital care
41. Prolonged beneficial effects of a home-based intervention on unplanned readmissions and mortality among patients with congestive heart failure
42. Prevention of hospitalizations for heart failure with an interactive home monitoring program
43. A multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure
44. Effect of mibefradil, a T-type calcium channel blocker, on morbidity and mortality in moderate to severe congestive heart failure: The MACH-1 study. Mortality Assessment in Congestive Heart Failure Trial
45. Calcium-channel blockers in cardiac failure
46. Efficacy and safety of calcium channel blockers in heart failure: Focus on recent trials with second-generation dihydropyridines
47. Effect of amlodipine on mode of death among patients with advanced heart failure in the PRAISE trial. Prospective randomized amlodipine survival evaluation
48. Calcium-channel blockade in the management of severe chronic congestive heart failure: A bridge too far
49. Hemodynamic and clinical benefits with intravenous milrinone in severe chronic heart failure: Results of a multicenter study in the United States
50. Intermittent dobutamine treatment in patients with chronic refractory congestive heart failure: A randomized, double-blind, placebo-controlled study
51. Effect of oral milrinone on mortality in severe chronic heart failure
52. Has the survival of the heart failure population changed? Lessons from trials
53. The epidemiology of heart failure: The Framingham Study
54. Mortality risk and patterns of practice in 4606 acute care patients with congestive heart failure. The relative importance of age, sex, and medical therapy
55. Survival of patients with a new diagnosis of heart failure: A population-based study
56. Antithrombotic therapy in atrial fibrillation
57. Drugs, heart failure and quality of life: What are we achieving? What should we be trying to achieve?
58. Failure of women's hearts
59. Outcomes for older men and women with congestive heart failure
60. Gender differences in 1-year survival and quality of life among patients admitted with congestive heart failure
61. Racial differences in the outcome of left ventricular dysfunction
62. Congestive heart failure hospitalizations and survival in California: Patterns according to race/ethnicity
63. Influence of race and gender on care process, resource use, and hospital-based outcomes in congestive heart failure
64. Treatment of patients admitted to the hospital with congestive heart failure: Specialty related disparities in practice patterns and outcomes
65. Cardiology or primary care for heart failure in the community setting. Process of care and clinical outcomes
66. Variations in family physicians' and cardiologists' care for patients with heart failure